Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : profit beats as pharmacy margins rise

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/02/2017 | 06:06pm CEST
People walk outside a CVS store in Pasadena

CVS Health Corp (>> CVS Health Corp) reported a bigger-than-expected quarterly profit as higher margins in its pharmacy business helped offset the loss of major contracts last year.

CVS Health Corp (>> CVS Health Corp) reported a bigger-than-expected quarterly profit as higher margins in its pharmacy business helped offset the loss of major contracts last year.

Same-store prescription volumes fell 460 basis points in the first quarter due to the loss of contracts to fill prescriptions for Tricare, a U.S. Department of Defense health care program, and for customers of pharmacy benefits manager Prime Therapeutics, to rival Walgreens Boots Alliance Inc (>> Walgreens Boots Alliance Inc).

However, higher generic drug dispensing rate and a cut back on promotions at the front-end of the store lifted gross margin in the pharmacy business by about 35 basis points to 29.4 percent.

Front-end same-store sales fell 4.9 percent in the first three months ended March 31. The company sells beauty products, snacks and over-the-counter drugs at the front-end of its nearly 9,700 stores.

Front-end same-store sales slipped for the fourth straight quarter and the company has been investing to turn around sales by improving the store layout and product assortment.

CVS reiterated its 2017 profit forecast and estimated second-quarter adjusted earnings largely below analysts' average estimate of $1.33 per share.

The company's shares were down 2 percent at $80.23 in morning trading on Tuesday. Through Monday's close, they had gained 5.4 percent since Walgreens reported a surprise drop in sales last month.

Revenue in CVS's bigger pharmacy services business rose 8.5 percent to $31.2 billion as claims increased across its network and on strong demand for its specialty pharmacy service.

The specialty pharmacy service provides expensive drugs to people with chronic conditions such as rheumatoid arthritis.

Net income attributable to CVS fell to $952 million, or 92 cents per share, in the first quarter, from $1.15 billion, or $1.04 per share, a year earlier.

Interest expenses declined 11 percent to $252 million, while the company also got $19 million in tax benefits from the adoption of new accounting guidance for share-based compensation.

Excluding items, the company earned $1.17 per share.

Revenue rose 3 percent to $44.51 billion.

Analysts on average had expected earnings of $1.10 per share on revenue of $44.20 billion, according to Thomson Reuters I/B/E/S.

(Reporting by Sruthi Ramakrishnan in Bengaluru; Editing by Saumyadeb Chakrabarty and Sriraj Kalluvila)

Stocks treated in this article : CVS Health Corp, Walgreens Boots Alliance Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
08/23 CVS HEALTH : 's Accordant Earns NCQA Disease Management Accreditation for 18 Con..
08/21 CVS HEALTH CORP (NYSE : CVS) Study Reveals 66% of Americans Believe That Flu Sho..
08/19 CVS HEALTH : Laguna City Council to consider CVS' appeal to move into Laguna Dru..
08/19 INSIDER TRADING ACTIVITY CVS HEALTH : CVS) – Director Sold 2,500 shares o..
08/18 CVS HEALTH : SMART Clinic heads into its second year
08/18 UNITEDHEALTH : Corporate News Blog - UnitedHealth Group Announces New Leadership..
08/17 CVS PHARMACY : Earns URAC Reaccreditation in Community Pharmacy
08/17 CONSIDER YOUR PURPOSE : PA and PharmD Students Receive Short White Coats
08/16 CVS HEALTH : Prom night at YMCA Camp Oakes
08/16 CVS HEALTH : Survey Reveals Two in Three Americans who plan to get a Flu Shot Be..
More news
News from SeekingAlpha
08/22 5 Cheapest Funds For Dividend Investors
08/21 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2017 Upda..
08/18 CVS Health Corporation 2017 Q2 - Results - Earnings Call Slides
08/18 This Bottoming Healthcare Stock Just Narrowed Its Guidance
08/17 TARGET REPORTS Q2 : Updating My Bullish Comments From Last Month
Financials ($)
Sales 2017 184 098 M
EBIT 2017 10 053 M
Net income 2017 5 304 M
Debt 2017 24 744 M
Yield 2017 2,54%
P/E ratio 2017 15,44
P/E ratio 2018 13,20
EV / Sales 2017 0,56x
EV / Sales 2018 0,54x
Capitalization 79 048 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 86,6 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-1.61%79 048
WALGREENS BOOTS ALLIANCE-1.79%86 977
EXPRESS SCRIPTS HOLDING CO-10.42%35 589
MCKESSON CORPORATION5.57%31 177
CARDINAL HEALTH INC-10.55%20 702
AMERISOURCEBERGEN CORP.1.33%17 360